Cleared Special

K032600 - VAXCEL PORT, MODEL 45-333 AND VAXCEL W/PASV PORT, MODEL 45-233 (FDA 510(k) Clearance)

Sep 2003
Decision
15d
Days
Class 2
Risk

K032600 is an FDA 510(k) clearance for the VAXCEL PORT, MODEL 45-333 AND VAXCEL W/PASV PORT, MODEL 45-233. This device is classified as a Port & Catheter, Implanted, Subcutaneous, Intravascular (Class II - Special Controls, product code LJT).

Submitted by Boston Scientific Corp (Glens Falls, US). The FDA issued a Cleared decision on September 9, 2003, 15 days after receiving the submission on August 25, 2003.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5965.

Submission Details

510(k) Number K032600 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 25, 2003
Decision Date September 09, 2003
Days to Decision 15 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code LJT — Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5965

Similar Devices — LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

Vaccess™ CT Low-Profile Power-Injectable Implantable Port
K252478 · Bard Access Systems, Inc. · Sep 2025
PowerPort™ isp Implantable Port
K251253 · Bard Access Systems, Inc. · Jun 2025
PowerPort™ ClearVUE™ Slim Implantable Ports and PowerPort™ ClearVUE™ Slim Implantable Ports
K242328 · Bard Access Systems, Inc. · Oct 2024
PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port
K232737 · Bard Peripheral Vascular, Inc. · Dec 2023